Fatal intestinal lesions in coronavirus infection
https://doi.org/10.24884/1609-2201-2024-103-2-57-60
Abstract
In the clinic of coronavirus infection (SARS-CoV-2), inflammatory symptoms of the upper respiratory tract and pulmonary parenchyma prevail, and intestinal damage and the appearance of digestive symptoms are more characteristic of long-term pathology. The aim of the study was to retrospective analyze fatal cases of intestinal lesions in a new Covid-19 infection. In total, 9 patients with fatal intestinal lesions were identified out of a total of 2,781 deaths during the three years of operation of the Nikolaevskaya Hospital hospital in St. Petersburg, which was repurposed to provide medical care to patients with the new coronavirus infection Covid-19 (SARS-Cov-2). The described pathoanatomical manifestations in the form of mesenteric vascular thrombosis and wall necrosis, corresponding to the clinical definition of «fatal intestinal lesion», are recognized as conditions incompatible with life and unavoidable at the stage of qualified and specialized therapeutic care.
About the Authors
V. N. Katyukhin
Medical University «Reaviz»
Russian Federation
Russian Federation
Valery N. Katyukhin, Dr. of Sci. (Med.), Professor, Head of Department of Internal Medicine
8, Kalinina St., building 2, lit. A., Saint Petersburg, 199098
K. L. Avakyan
Nikolaev Hospital
Russian Federation
Russian Federation
Karapet L. Avakyan, Head of Pathology Department
Saint Petersburg
N. G. Khadikova
Medical University «Reaviz» ; Nikolaev Hospital
Russian Federation
Russian Federation
Nadezhda G. Khadikova, Cand. of Sci. (Med.), Associate Professor, Department of Internal Medicine, Deputy Chief Physician for Internal Medicine
Saint Petersburg
References
1. Katyukhin V. N. Consequens of Coronovirus Infection: Clinical Manifestations, Diagnosis and Treatment Tactics. EC Clinical and Medical Case Reports. 2023;6(11):01–05.
2. Berenguera A., Jacques-Aviñó C., Medina-Perucha L., Puente D. Long term consequences of COVID-19. Eur. J. Intern. Med. 2021;9:34–35. DOI: 10.1016/j.ejim.2021.08.022.
3. Carfì A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. DOI: 10.1001/jama.2020.12603.
4. Arnold D. T., Hamilton F. W., Milne A. et al. Patient outcomes after hospitalization with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399– 401. DOI: 10.1136/thoraxjnl-2020-216086.
5. Sarsenbaeva A. S., Lazebnik L. B. Features of intestinal lesions in COVID-19. Experimental and Clinical Gastroenterology. 2020;(12):16–22. (In Russ). DOI: 10.31146/1682-8658-ecg-184-12-16-22.
6. Uhlenhopp D. J., Ramachandran R., Then E. at al. COVID-19-Associated Ischemic Colitis: A Rare Manifestation of COVID-19 Infection-Case Report and Review. J. Investig. Med. High Impact Case Rep. 2022;10:23247096211065625. DOI: 10.1177/23247096211065625. PMID: 35343847; PMCID: PMC8966066.
7. Prevention, diagnosis and treatment of novel coronavirus infection (covid-19) : Interim methodological recommendations. Version 18 (26.10.2023). Ministry Of Health Of The Russian Federation. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/064/610/original/%D0%92%D0%9C%D0%A0_COVID-19_V18.pdf (accessed: 20.08.24). (In Russ).
8. Vorobyeva N. A., Vorobyeva A. I., Vorontsova A. S. Predicting the risk of prothrombogenic readiness in Covid-19 infection using genetic testing. Health Risk Analysis. 2023;2:130–139. (In Russ). DOI: 10.21668/health.risk/2023.2.12.
Review
For citations:
Katyukhin V.N., Avakyan K.L., Khadikova N.G. Fatal intestinal lesions in coronavirus infection. New St. Petersburg Medical Records. 2024;(2):57-60. (In Russ.) https://doi.org/10.24884/1609-2201-2024-103-2-57-60
Views:
111
Email this article 